1
Thomas E Rogers, Steven H Gray, Balekudru Devadas, Steven P Adams: Improved probes using nucleosides containing 3-dezauracil analogs. Monsanto Company, Dennis A Bennett, July 28, 1992: US05134066 (253 worldwide citation)

The deazauracil containing probes of the invention are able to withstand higher temperatures, thereby allowing unmatched probes and mismatched probes to be washed off at higher hybridization stringency, thereby eliminating background readings and improving ease and accuracy of probe use.


2
Philippe R Bovy, Joseph G Rico, Thomas E Rogers, Foe S Tjoeng, Jeffery A Zablocki: Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors. G D Searle & Co, Monsanto Company, Dennis A Bennett, September 6, 1994: US05344957 (26 worldwide citation)

Novel substituted .beta. amino acid derivatives are provided which inhibit platelet aggregation. This invention also pertains to pharmaceutical compositions and methods of using such derivatives.


3
Philippe R Bovy, Joseph G Rico, Thomas E Rogers, Foe S Tjoeng, Jeffery A Zablocki: Substituted heterocyclic derivatives useful as platelet aggregation inhibitors. Monsanto Company, G D Searle & Co, Dennis A Bennett, October 19, 1993: US05254573 (23 worldwide citation)

Novel substituted heterocyclic derivatives are provided which inhibit platelet aggregation. This invention also pertains to pharmaceutical compositions and methods of using such derivatives.


4
Phillipe R Bovy, Joseph G Rico, Thomas E Rogers, Foe S Tjoeng, Jeffery A Zablocki: Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof. Monsanto Company, G D Searle & Co, Dennis A Bennett, August 24, 1993: US05239113 (20 worldwide citation)

Novel substituted .beta. amino acid derivatives are provided which inhibit platelet aggregation and intermediates thereof. This invention also pertains to pharmaceutical compositions and methods of using such derivatives.


5
Thomas E Rogers: Process for preparing glyphosate and glyphosate derivatives. Monsanto Company, Raymond C Loyer, Frank D Shearin, February 4, 1986: US04568432 (17 worldwide citation)

A process for preparing glyphosate and derivatives of related structure. A precursor primary or secondary amine, such as glycine, is condensed with a carbonyl compound, such as formylphosphonic acid or its acetals, and the condensation product is reduced to produce the desired product.


6
Thomas E Rogers, Robert E Jansson, Manuel M Baizer: Electrolysis cells and electrolytic processes. Monsanto Company, Joseph D Kennedy, James W Williams Jr, July 3, 1984: US04457813 (16 worldwide citation)

Electrolytic processes in which separate useful reactions are conducted at an anode and cathode, respectively, by electrolysis of an anolyte at an anode and a catholyte at the cathode wherein the anolyte and catholyte are of different composition and are prevented from contacting the cathode and ano ...


7
Philippe R Bovy, Joseph G Rico, Thomas E Rogers, Foe S Tjoeng, Jeffery A Zablocki: Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors. G D Searle & Co, The Monsanto Company, Cynthia S Kovacevic, Roger A Williams, December 30, 1997: US05703125 (15 worldwide citation)

The invention relates to platelet aggregation inhibitors which are substituted beta amino acid derivatives of the formula: ##STR1## wherein Z, A, Z', Z", W, q, R.sup.1 and R.sup.2 are as defined in the specification.


8
Barbara B Chen, Helen Y Chen, Glen J Gesicki, Richard A Haack, James W Malecha, Thomas D Penning, Joseph G Rico, Thomas E Rogers, Peter G Ruminski, Mark A Russell, Stella S Yu: Para-substituted phenylene derivatives. G D Searle & Co, Cynthia S Kovacevic, September 14, 1999: US05952381 (14 worldwide citation)

The present invention relates to a class of compounds represented by Formula I ##STR1## or a pharmaceutically acceptable salt thereof, pharmaceutical composition comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the .alpha..sub.v .beta..sub.3 integrin.


9
Philippe R Bovy, Joseph G Rico, Thomas E Rogers, Foe S Tjoeng, Jeffery A Zablocki: Substituted bicyclic heterocyclic compounds useful as platelet aggregation inhibitors. G D Searle & Co, Cynthia S Kovacevic, Roger A Williams, January 3, 1995: US05378727 (8 worldwide citation)

Novel substituted heterocyclic derivatives are provided which inhibit platelet aggregation. This invention also pertains to pharmaceutical compositions and methods of using such derivatives.


10
Joe T Collins, Balekudru Devadas, Hwang fun Lu, James W Malecha, Julie Marion Miyashiro, Srinivasan Nagarajan, Joseph Gerace Rico, Thomas E Rogers: Amino benzenepropanoic acid compounds and derivatives thereof. G D Searle & Co, Cynthia S Kovacevic, August 8, 2000: US06100423 (7 worldwide citation)

The present invention is directed to compounds of the formula ##STR1## where R.sup.1 is BOC or H, R is H or lower alkyl; X and Y are the same or different halo atoms selected from the group consisting of Cl, Br or I and pharmaceutically acceptable salts and isomers thereof.